| Consumers | End users interested in health and wellness | Enhance product trust through philanthropic activities; strengthen company image in terms of contributing to health improvement | - Consumer education programs, health campaigns- Convey the social value of products and the company’s commitment through patient support programs |
| Investors and Shareholders | Interested in investment returns and the company’s long-term sustainability | Emphasize the company’s sustainability and social responsibility through philanthropic activities | - Sustainability reports- Announcements of philanthropic activity results- Sharing ESG performance |
| Policymakers and Government Agencies | Influence policy formation and execution | Implement health policies; enhance policy support and collaboration | - Policy briefings- Public partnership programs- Participation in government-led health campaigns |
| Medical Professionals and Institutions | Make decisions about prescribing, recommending, and using products | Increase trust in products and company through philanthropic activities | - Medical education seminars- Provision of research data- Development of collaborative health programs |
| NGOs and Social Enterprises | Interested in social value and effect | Strengthen the connection between social goals and pharmaceutical industry goals | - Collaborative projects- Contribution to Sustainable Development Goals- Joint research and activities |
| Internal Employees (excluding subject) | Core members of company operations; effect on internal motivation and participation | Increase awareness of corporate culture and the importance of philanthropic activities among employees | - Share philanthropic activities through internal communication channels- Employee engagement programs, volunteering opportunities |